Skip To Main Content
Susan Ringdal on Muck Rack

Susan Ringdal

As seen in: ADVFN, This is Money
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Susan Ringdal’s profile

Articles by Susan Ringdal

Hikma Pharmaceuticals Plc Trading Statement (0980S)

|
By Susan Ringdal
| ADVFN
Register for real-time alerts, custom portfolio, and market movers Share Name Share Symbol Market Type Share ISIN Share Description Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade 0.00 0.0% 1,920.00 1,922.00 1,924.50 0.00 00:00:00 Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m) Pharmaceutical Preparations - 188.0 80.7...
Open in Who Shared View Duplicates (9) Issue with article?

Hikma Pharmaceuticals Plc Hikma appoints new President of Injectables

|
By Susan Ringdal, Charles Armitstead
| ADVFN
Hikma Pharmaceuticals (LSE:HIK) Intraday Stock Chart Wednesday 9 August 2023 TIDMHIK RNS Number : 7127I Hikma Pharmaceuticals Plc 09 August 2023 Hikma appoints new President of Injectables business London, 9 August 2023 - Hikma Pharmaceuticals PLC and its subsidiaries ('Hikma' or 'Group'), the multinational pharmaceutical company, announce that Dr. Bill Larkins has been appointed President of its Injectables business, effective 1 September 2023.
Open in Who Shared View Duplicates (10) Issue with article?

Hikma Pharmaceuticals Plc Half-year Report

|
By Susan Ringdal, Charles Armitstead
| ADVFN
Hikma Pharmaceuticals (LSE:HIK) Intraday Stock Chart Thursday 3 August 2023 TIDMHIK RNS Number : 1402I Hikma Pharmaceuticals Plc 03 August 2023 Hikma delivers strong H1 performance and raises Generics guidance Growth in all three businesses and across all geographies London, 3 August 2023 - Hikma Pharmaceuticals PLC and its subsidiaries ('Hikma' or 'Group'), the multinational pharmaceutical company, today reports its interim results for the six months ended 30 June 2023.
Open in Who Shared Issue with article?

Hikma Pharmaceuticals Plc Notice of Results

|
By Susan Ringdal
| ADVFN
Hikma Pharmaceuticals (LSE:HIK) Intraday Stock Chart Monday 17 July 2023 TIDMHIK RNS Number : 2187G Hikma Pharmaceuticals Plc 17 July 2023 London, 17 July 2023 - Hikma Pharmaceuticals PLC (Hikma, Group), will announce its interim financial results for the six months ended 30 June 2023 on Thursday 3 August 2023. A recording of the presentation will be available on the Group's website at www.hikma.com from 7:00am BST.
Open in Who Shared View Duplicates (2) Issue with article?

Hikma Pharmaceuticals Plc Trading Statement

|
By Susan Ringdal
| ADVFN
Hikma Pharmaceuticals (LSE:HIK) Intraday Stock Chart Friday 28 April 2023 TIDMHIK RNS Number : 7691X Hikma Pharmaceuticals Plc 28 April 2023 Good momentum across all businesses and updated Generics guidance London, 28 April 2023 - Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading ahead of its Annual General Meeting. Said Darwazah, Hikma's Executive Chairman and CEO, said: "Hikma has had a good start to the year.
Open in Who Shared View Duplicates (6) Issue with article?

Hikma Pharmaceuticals Plc Directorate Change

|
By Susan Ringdal
| ADVFN
Hikma Pharmaceuticals (LSE:HIK) Intraday Stock Chart Wednesday 12 April 2023 TIDMHIK RNS Number : 8939V Hikma Pharmaceuticals Plc 12 April 2023 Riad Mishlawi named Chief Executive Officer of Hikma Pharmaceuticals PLC London, 12 April 2023 - Hikma Pharmaceuticals PLC (Hikma, Group), announces that Riad Mishlawi, President of the Group's Injectables business, has been appointed Chief Executive Officer (CEO), effective 1 September 2023.
Open in Who Shared View Duplicates (8) Issue with article?

Hikma Pharmaceuticals Plc Final Results

|
By - Full-year dividend, Susan Ringdal, Charles Armitstead, As at As
| ADVFN
Share Name Share Symbol Market Type Share ISIN Share Description Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade 78.50 4.48% 1,832.00 1,830.50 1,835.00 1,842.50 1,763.50 1,764.50 58,997 08:43:56 Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m) Pharmaceuticals & Biotechnology 1,887.9 402.3 134.8 12.1 4,241 Hikma...
Open in Who Shared Issue with article?
Show More